This is a Validated Antibody Database (VAD) review about dog CD80, based on 87 published articles (read how Labome selects the articles), using CD80 antibody in all methods. It is aimed to help Labome visitors find the most suited CD80 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD80 synonym: T-lymphocyte activation antigen CD80; B7-1 protein; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); T-cell co-stimulatory protein B7-1

BioLegend
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s6c
BioLegend CD80 antibody (BioLegend, 104723) was used in flow cytometry on mouse samples (fig s6c). Cell (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4b
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 4b). J Clin Invest (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3b
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 3b). Sci Rep (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 4e
BioLegend CD80 antibody (Biolegend, 104705) was used in flow cytometry on mouse samples (fig 4e). Cell (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD80 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1a). Science (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend CD80 antibody (BioLegend, 16-0A1) was used in flow cytometry on mouse samples (fig s1c). J Immunol (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend CD80 antibody (Biolegend, 104708) was used in flow cytometry on mouse samples (fig 2e). Cell Rep (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s5
BioLegend CD80 antibody (Biolegend, 104732) was used in flow cytometry on mouse samples (fig s5). Nat Commun (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1n
BioLegend CD80 antibody (BioLegend, 104734) was used in flow cytometry on mouse samples (fig 1n). Cell Mol Gastroenterol Hepatol (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 3a). Front Immunol (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; loading ...; fig s1
BioLegend CD80 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples at 1:100 (fig s1). Nat Commun (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig s6d
BioLegend CD80 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig s6d). JCI Insight (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 5b
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend CD80 antibody (Biolegend, 104706) was used in flow cytometry on mouse samples (fig 5b). Cell Death Dis (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...
In order to evaluate mouse models of hepacivirus infection, BioLegend CD80 antibody (Biolegend, 16-10AI) was used in flow cytometry on mouse samples . Science (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend CD80 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 5c). Cancer Res (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1b). J Leukoc Biol (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig s2b). J Exp Med (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3a
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, BioLegend CD80 antibody (biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 3a). J Exp Med (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 2b). Immunology (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 6c
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 6c). J Immunol (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig s2b). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (16-10A1)
In order to assess the effects of a genetically encoded chimeric MyD88/CD40 adjuvant, BioLegend CD80 antibody (BioLegend, 104722) was used . PLoS ONE (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s4b
In order to use a CRISPR-Cas9 system to screen for genes involved in B-cell activation and plasma cell differentiation, BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig s4b). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s4e
In order to study T cell migration in inflammatory demyelinating lesions confined to optic nerves and spinal cord, BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig s4e). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 4b
In order to probe how neutrophil extracellular traps modulate the rheumatoid arthritis-associated autoimmune response, BioLegend CD80 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 4b). Eur J Immunol (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; loading ...; fig 9b
In order to investigate the contribution of neutrophils and macrophages during Rickettsia typhi infection, BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples at 1:100 (fig 9b). PLoS Negl Trop Dis (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:400; loading ...; fig 1a
BioLegend CD80 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples at 1:400 (fig 1a). PLoS ONE (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 1a
BioLegend CD80 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1a). PLoS ONE (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the protective immunological events induced by vaccination with Leishmune in dogs, BioLegend CD80 antibody (Biolegend, 104718) was used in flow cytometry on human samples (tbl 2). Vet Parasitol (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3e
In order to compare the capacity of induced T regulatory and T helper 17 cells to develop in a T cell model of colitis, BioLegend CD80 antibody (BioLegend, 16- 10A1) was used in flow cytometry on mouse samples (fig 3e). J Immunol (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4
In order to study dendritic cells in Sirt6 knock out mice, BioLegend CD80 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 4). Aging (Albany NY) (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of miR-34a in efferocytosis, BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 1
In order to determine the promotion of the formation of conjugates between transformed T helper cells and B lymphoma cells by murid gammaherpesvirus latency-associated protein M2, BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 2j
BioLegend CD80 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 2j). Sci Rep (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 8
In order to study engineered anti-melanoma vaccines that modulate cytokine priming and silence PD-L1 simultaneously by use of ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy, BioLegend CD80 antibody (BioLegend, 104713) was used in flow cytometry on mouse samples (fig 8). Oncoimmunology (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 1
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 1
BioLegend CD80 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1). Biochem Biophys Res Commun (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 3). PLoS Pathog (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100
In order to assess the role of CDH17 in the long-term survival of memory B cells in the bone marrow, BioLegend CD80 antibody (BioLegend, 104717) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
BioLegend CD80 antibody (BioLegend, 104714) was used . PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend CD80 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig s2b). J Leukoc Biol (2014) ncbi
Invitrogen
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen CD80 antibody (eBioscience, 16-10A-1) was used in flow cytometry on mouse samples (fig 1b). Front Immunol (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 6c
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 6c). Immune Netw (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3h
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 3h). Glia (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s2
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig s2). Proc Natl Acad Sci U S A (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig e5c
Invitrogen CD80 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (fig e5c). Nature (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 5d). J Leukoc Biol (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5a
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:400; loading ...; fig s5
In order to report a CD40-dependent mechanism capable of abrogating inducible T regulatory cell induction by dendritic cells, Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples at 1:400 (fig s5). Nat Commun (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3a
In order to study the D. farinae allergen Pplase in a mouse model., Invitrogen CD80 antibody (Ebioscience, 12-0801) was used in flow cytometry on mouse samples (fig 3a). Sci Rep (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3a
In order to test the effect of paeoniflorin in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, Invitrogen CD80 antibody (eBioscience, 11-0801) was used in flow cytometry on mouse samples (fig 3a). Sci Rep (2017) ncbi
hamsters monoclonal (16-10A1)
  • blocking or activating experiments; mouse; loading ...; fig 7
In order to explore if the binding strength of a peptide for a MHC is a critical factor to determine the duration of pMHC-mediated T cell activation, Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in blocking or activating experiments on mouse samples (fig 7). Mol Cells (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5n
In order to evaluate miR-29a in B cells as a potential therapeutic target in arthritis, Invitrogen CD80 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 5n). Cell Mol Life Sci (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2b
In order to study the ability of lymphocyte-derived microparticles to modulate the gene expression pattern of angiogenesis-related factors in macrophages, Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 2b). Sci Rep (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4B
In order to study the contribution of CXCR6/CXCL16 interactions in glycolipid-dependent invariant natural killer cell activation and tumor control, Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 4B). Oncoimmunology (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig s2b
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig s2b). Immunity (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...; fig s2b
In order to elucidate the mechanistic relationships among TLRs, CD80, and albuminuria, Invitrogen CD80 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples at 1:200 (fig s2b). Dis Model Mech (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig s8
Invitrogen CD80 antibody (eBioscience, 12-0801-85) was used in flow cytometry on mouse samples (fig s8). Sci Rep (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; fig 2
In order to determine the affects of dendritic cell migration in vitro by loss of gadkin, Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples at 1:100 (fig 2). PLoS ONE (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5a
In order to parse the relative importance of the direct and indirect antigen presentation pathways in ectromelia virus mouse pox infection., Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 5a). PLoS Pathog (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; tbl s1
In order to study the role of ICOS in group 2 innate lymphoid cell responses, Invitrogen CD80 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . Nature (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig s3
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 3). Carbohydr Polym (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s2b
In order to test if blocking several checkpoint receptors boosts anti-tumor immunity in a low-dose, lymphodepleting whole body radiation model, Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig s2b). J Immunother Cancer (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . Mucosal Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 2
Invitrogen CD80 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 5a
In order to test the efficacy of combining different monoclonal antibodies to treat cancer, Invitrogen CD80 antibody (ebioscience, 14-0801-82) was used in flow cytometry on mouse samples (fig 5a). Clin Cancer Res (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4
In order to investigate the use of mannosylated synthetic long peptides for vaccination, Invitrogen CD80 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; fig 2
Invitrogen CD80 antibody (eBioscience, 11-0801-86) was used in flow cytometry on mouse samples at 1:100 (fig 2). PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen CD80 antibody (eBioscience Inc., 16-10A1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; human
Invitrogen CD80 antibody (eBioscience, 17-0801-82) was used in flow cytometry on human samples . J Immunol (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3
In order to elucidate the role of dendritic cells in cancer immunosurveillance failure, Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 3). Immunol Cell Biol (2013) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . J Exp Med (2011) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 5
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 5). J Immunol (2010) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 5
In order to test if upregulation of major histocompatibility complex class II and costimulatory molecules in the retina contributes to the regulation of CD4 T cells, Invitrogen CD80 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 5). Infect Immun (2010) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 4). J Immunol (2009) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
In order to investigate crosstalk between that osteoclasts and T cells, Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
In order to examine the origin and development of Aire positive medullary thymic epithelial cells, Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . Nat Immunol (2007) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 5
  • flow cytometry; human
Invitrogen CD80 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 5) and in flow cytometry on human samples . J Immunol (2005) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
In order to investigate the use of three-domain single-chain T-cell receptors, Invitrogen CD80 antibody (Caltag, 16-10A1) was used in flow cytometry on mouse samples . Cancer Gene Ther (2004) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
In order to generate and characterize mice deficient for CD37, Invitrogen CD80 antibody (Biosource, 16-10A1) was used in flow cytometry on mouse samples . Mol Cell Biol (2000) ncbi
Articles Reviewed
  1. Wolf Y, Bartok O, Patkar S, Eli G, Cohen S, Litchfield K, et al. UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma. Cell. 2019;179:219-235.e21 pubmed publisher
  2. Sivaram N, McLaughlin P, Han H, Petrenko O, Jiang Y, Ballou L, et al. Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. J Clin Invest. 2019;130: pubmed publisher
  3. Humeniuk P, Geiselhart S, Battin C, Webb T, Steinberger P, Paster W, et al. Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor. Sci Rep. 2019;9:7426 pubmed publisher
  4. Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells. Cell. 2019;177:1172-1186.e14 pubmed publisher
  5. Mizuno R, Sugiura D, Shimizu K, Maruhashi T, Watada M, Okazaki I, et al. PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation. Front Immunol. 2019;10:630 pubmed publisher
  6. Sugiura D, Maruhashi T, Okazaki I, Shimizu K, Maeda T, Takemoto T, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558-566 pubmed publisher
  7. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  8. Lee Y, Ju J, Shon W, Oh S, Min C, Kang M, et al. Skewed Dendritic Cell Differentiation of MyD88-Deficient Donor Bone Marrow Cells, Instead of Massive Expansion as Myeloid-Derived Suppressor Cells, Aggravates GVHD. Immune Netw. 2018;18:e44 pubmed publisher
  9. Düsedau H, Kleveman J, Figueiredo C, Biswas A, Steffen J, Kliche S, et al. p75NTR regulates brain mononuclear cell function and neuronal structure in Toxoplasma infection-induced neuroinflammation. Glia. 2019;67:193-211 pubmed publisher
  10. Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin G, Shurin M, et al. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci U S A. 2019;116:1361-1369 pubmed publisher
  11. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  12. Tordesillas L, Lozano Ojalvo D, Dunkin D, Mondoulet L, Agudo J, Merad M, et al. PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun. 2018;9:5238 pubmed publisher
  13. Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai M, Nomura E, et al. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells. Cell Mol Gastroenterol Hepatol. 2019;7:135-156 pubmed publisher
  14. Montero Herradón S, García Ceca J, Zapata A. Altered Maturation of Medullary TEC in EphB-Deficient Thymi Is Recovered by RANK Signaling Stimulation. Front Immunol. 2018;9:1020 pubmed publisher
  15. Yao Y, Huang W, Li X, Li X, Qian J, Han H, et al. Tespa1 Deficiency Dampens Thymus-Dependent B-Cell Activation and Attenuates Collagen-Induced Arthritis in Mice. Front Immunol. 2018;9:965 pubmed publisher
  16. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  17. Mencarelli A, Khameneh H, Fric J, Vacca M, El Daker S, Janela B, et al. Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis. Nat Commun. 2018;9:1102 pubmed publisher
  18. Pedros C, Canonigo Balancio A, Kong K, Altman A. Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity. JCI Insight. 2017;2: pubmed publisher
  19. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  20. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  21. Akiel M, Guo C, Li X, Rajasekaran D, Mendoza R, Robertson C, et al. IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Res. 2017;77:4014-4025 pubmed publisher
  22. Cao Y, Zhang E, Yang J, Yang Y, Yu J, Xiao Y, et al. Frontline Science: Nasal epithelial GM-CSF contributes to TLR5-mediated modulation of airway dendritic cells and subsequent IgA response. J Leukoc Biol. 2017;102:575-587 pubmed publisher
  23. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  24. Shrestha B, You D, Saravia J, Siefker D, Jaligama S, Lee G, et al. IL-4R? on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection. J Leukoc Biol. 2017;102:153-161 pubmed publisher
  25. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  26. Inoue T, Shinnakasu R, Ise W, Kawai C, Egawa T, Kurosaki T. The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help. J Exp Med. 2017;214:1181-1198 pubmed publisher
  27. Kogo H, Shimizu M, Negishi Y, Uchida E, Takahashi H. Suppression of murine tumour growth through CD8+ cytotoxic T lymphocytes via activated DEC-205+ dendritic cells by sequential administration of ?-galactosylceramide in vivo. Immunology. 2017;151:324-339 pubmed publisher
  28. Barthels C, Ogrinc A, Steyer V, Meier S, Simon F, Wimmer M, et al. CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis. Nat Commun. 2017;8:14715 pubmed publisher
  29. Wang H, Mo L, Xiao X, An S, Liu X, Ba J, et al. Pplase of Dermatophagoides farinae promotes ovalbumin-induced airway allergy by modulating the functions of dendritic cells in a mouse model. Sci Rep. 2017;7:43322 pubmed publisher
  30. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed publisher
  31. Hwang I, Kim K, Choi S, Lomunova M. Potentiation of T Cell Stimulatory Activity by Chemical Fixation of a Weak Peptide-MHC Complex. Mol Cells. 2017;40:24-36 pubmed publisher
  32. van Nieuwenhuijze A, Dooley J, Humblet Baron S, Sreenivasan J, Koenders M, Schlenner S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74:2095-2106 pubmed publisher
  33. Khameneh H, Ho A, Spreafico R, Derks H, Quek H, Mortellaro A. The Syk-NFAT-IL-2 Pathway in Dendritic Cells Is Required for Optimal Sterile Immunity Elicited by Alum Adjuvants. J Immunol. 2017;198:196-204 pubmed
  34. Tahiri H, Omri S, Yang C, Duhamel F, Samarani S, Ahmad A, et al. Lymphocytic Microparticles Modulate Angiogenic Properties of Macrophages in Laser-induced Choroidal Neovascularization. Sci Rep. 2016;6:37391 pubmed publisher
  35. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  36. Collinson Pautz M, Slawin K, Levitt J, Spencer D. MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity. PLoS ONE. 2016;11:e0164547 pubmed publisher
  37. Chu V, Graf R, Wirtz T, Weber T, Favret J, Li X, et al. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line. Proc Natl Acad Sci U S A. 2016;113:12514-12519 pubmed
  38. Klotz L, Kuzmanov I, Hucke S, Gross C, Posevitz V, Dreykluft A, et al. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6182-E6191 pubmed
  39. Papadaki G, Kambas K, Choulaki C, Vlachou K, Drakos E, Bertsias G, et al. Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation. Eur J Immunol. 2016;46:2542-2554 pubmed publisher
  40. Papp S, Moderzynski K, Rauch J, Heine L, Kuehl S, Richardt U, et al. Liver Necrosis and Lethal Systemic Inflammation in a Murine Model of Rickettsia typhi Infection: Role of Neutrophils, Macrophages and NK Cells. PLoS Negl Trop Dis. 2016;10:e0004935 pubmed publisher
  41. Kouwenberg M, Jacobs C, van der Vlag J, Hilbrands L. Allostimulatory Effects of Dendritic Cells with Characteristic Features of a Regulatory Phenotype. PLoS ONE. 2016;11:e0159986 pubmed publisher
  42. Veinotte L, Gebremeskel S, Johnston B. CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFN? production and tumor control. Oncoimmunology. 2016;5:e1160979 pubmed publisher
  43. Wang S, Xia P, Chen Y, Huang G, Xiong Z, Liu J, et al. Natural Killer-like B Cells Prime Innate Lymphocytes against Microbial Infection. Immunity. 2016;45:131-44 pubmed publisher
  44. Engelmann R, Biemelt A, Cordshagen A, Johl A, Kuthning D, Müller Hilke B. The Prerequisites for Central Tolerance Induction against Citrullinated Proteins in the Mouse. PLoS ONE. 2016;11:e0158773 pubmed publisher
  45. Jain N, Khullar B, Oswal N, Banoth B, Joshi P, Ravindran B, et al. TLR-mediated albuminuria needs TNF?-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice. Dis Model Mech. 2016;9:707-17 pubmed publisher
  46. Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed publisher
  47. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed publisher
  48. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  49. Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, et al. Sirt6 regulates dendritic cell differentiation, maturation, and function. Aging (Albany NY). 2016;8:34-49 pubmed
  50. McCubbrey A, Nelson J, Stolberg V, Blakely P, McCloskey L, Janssen W, et al. MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1. J Immunol. 2016;196:1366-75 pubmed publisher
  51. Schachtner H, Weimershaus M, Stache V, Plewa N, Legler D, Höpken U, et al. Loss of Gadkin Affects Dendritic Cell Migration In Vitro. PLoS ONE. 2015;10:e0143883 pubmed publisher
  52. Fontinha D, Lopes F, Marques S, Alenquer M, Simas J. Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells. PLoS ONE. 2015;10:e0142540 pubmed publisher
  53. Sun L, Sun C, Liang Z, Li H, Chen L, Luo H, et al. FSP1(+) fibroblast subpopulation is essential for the maintenance and regeneration of medullary thymic epithelial cells. Sci Rep. 2015;5:14871 pubmed publisher
  54. Sun L, Hua Y, Vergarajauregui S, Diab H, Puertollano R. Novel Role of TRPML2 in the Regulation of the Innate Immune Response. J Immunol. 2015;195:4922-32 pubmed publisher
  55. Sei J, Haskett S, Kaminsky L, Lin E, Truckenmiller M, Bellone C, et al. Peptide-MHC-I from Endogenous Antigen Outnumber Those from Exogenous Antigen, Irrespective of APC Phenotype or Activation. PLoS Pathog. 2015;11:e1004941 pubmed publisher
  56. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed publisher
  57. Liechtenstein T, Perez Janices N, Blanco Luquin I, Goyvaerts C, Schwarze J, Dufait I, et al. Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy. Oncoimmunology. 2014;3:e945378 pubmed
  58. Carmi Y, Spitzer M, Linde I, Burt B, Prestwood T, Perlman N, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015;521:99-104 pubmed publisher
  59. Sharma S, Chintala N, Vadrevu S, Patel J, Karbowniczek M, Markiewski M. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J Immunol. 2015;194:5529-38 pubmed publisher
  60. Kolan S, Boman A, Matozaki T, Lejon K, Oldenborg P. Lack of non-hematopoietic SIRPα signaling disturbs the splenic marginal zone architecture resulting in accumulation and displacement of marginal zone B cells. Biochem Biophys Res Commun. 2015;460:645-50 pubmed publisher
  61. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed publisher
  62. Sun H, Zhang J, Chen F, Chen X, Zhou Z, Wang H. Activation of RAW264.7 macrophages by the polysaccharide from the roots of Actinidia eriantha and its molecular mechanisms. Carbohydr Polym. 2015;121:388-402 pubmed publisher
  63. Stack G, Jones E, Marsden M, Stacey M, Snelgrove R, Lacaze P, et al. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue. PLoS Pathog. 2015;11:e1004641 pubmed publisher
  64. Jing W, Gershan J, Weber J, Tlomak D, McOlash L, Sabatos Peyton C, et al. Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma. J Immunother Cancer. 2015;3:2 pubmed publisher
  65. Funakoshi S, Shimizu T, Numata O, Ato M, Melchers F, Ohnishi K. BILL-cadherin/cadherin-17 contributes to the survival of memory B cells. PLoS ONE. 2015;10:e0117566 pubmed publisher
  66. Ikeda T, Hirata S, Takamatsu K, Haruta M, Tsukamoto H, Ito T, et al. Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells. PLoS ONE. 2014;9:e115198 pubmed publisher
  67. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed publisher
  68. Yin Y, Qin T, Wang X, Lin J, Yu Q, Yang Q. CpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendrites. Mucosal Immunol. 2015;8:799-814 pubmed publisher
  69. McDonnell A, Lesterhuis W, Khong A, Nowak A, Lake R, Currie A, et al. Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy. Eur J Immunol. 2015;45:49-59 pubmed publisher
  70. Škrnjug I, Guzmán C, Rueckert C, Ruecker C. Cyclic GMP-AMP displays mucosal adjuvant activity in mice. PLoS ONE. 2014;9:e110150 pubmed publisher
  71. Dai M, Yip Y, Hellstrom I, Hellstrom K. Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies. Clin Cancer Res. 2015;21:1127-38 pubmed publisher
  72. Rauen J, Kreer C, Paillard A, van Duikeren S, Benckhuijsen W, Camps M, et al. Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice. PLoS ONE. 2014;9:e103755 pubmed publisher
  73. Assi H, Espinosa J, Suprise S, SOFRONIEW M, Doherty R, Zamler D, et al. Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM. PLoS ONE. 2014;9:e96318 pubmed publisher
  74. Qian L, Zhang M, Wu S, Zhong Y, Van Tol E, Cai W. Alkylglycerols modulate the proliferation and differentiation of non-specific agonist and specific antigen-stimulated splenic lymphocytes. PLoS ONE. 2014;9:e96207 pubmed publisher
  75. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed publisher
  76. Ramakrishnan R, Tyurin V, Tuyrin V, Veglia F, Condamine T, Amoscato A, et al. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. J Immunol. 2014;192:2920-31 pubmed publisher
  77. Xia S, Wei J, Wang J, Sun H, Zheng W, Li Y, et al. A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells. J Leukoc Biol. 2014;95:733-742 pubmed
  78. Harimoto H, Shimizu M, Nakagawa Y, Nakatsuka K, Wakabayashi A, Sakamoto C, et al. Inactivation of tumor-specific CD8? CTLs by tumor-infiltrating tolerogenic dendritic cells. Immunol Cell Biol. 2013;91:545-55 pubmed publisher
  79. Purtha W, Tedder T, Johnson S, Bhattacharya D, Diamond M. Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J Exp Med. 2011;208:2599-606 pubmed publisher
  80. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  81. Charles E, Joshi S, Ash J, Fox B, Farris A, Bzik D, et al. CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect Immun. 2010;78:3484-92 pubmed publisher
  82. Ellestad K, Tsutsui S, Noorbakhsh F, Warren K, Yong V, Pittman Q, et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol. 2009;183:298-309 pubmed publisher
  83. Kiesel J, Buchwald Z, Aurora R. Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J Immunol. 2009;182:5477-87 pubmed publisher
  84. Hamazaki Y, Fujita H, Kobayashi T, Choi Y, Scott H, Matsumoto M, et al. Medullary thymic epithelial cells expressing Aire represent a unique lineage derived from cells expressing claudin. Nat Immunol. 2007;8:304-11 pubmed
  85. Hoffmann P, Kench J, Vondracek A, Kruk E, Daleke D, Jordan M, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol. 2005;174:1393-404 pubmed
  86. Zhang T, He X, Tsang T, Harris D. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function. Cancer Gene Ther. 2004;11:487-96 pubmed
  87. Knobeloch K, Wright M, Ochsenbein A, Liesenfeld O, Lohler J, Zinkernagel R, et al. Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions. Mol Cell Biol. 2000;20:5363-9 pubmed